David McIntyre's Net Worth
$5 Million
Who is David McIntyre?
David McIntyre has an estimated net worth of $5 Million. This is based on reported shares across multiple companies, which include HeartWare International, Inc., and Avita Therapeutics, Inc..
SEC CIK
David McIntyre's CIK is 0001404254
Past Insider Trading and Trends
2010 was David McIntyre's most active year for acquiring shares with 14 total transactions. David McIntyre's most active month to acquire stocks was the month of November. 2009 was David McIntyre's most active year for disposing of shares, totalling 25 transactions. David McIntyre's most active month to dispose stocks was the month of November. 2010 saw David McIntyre paying a total of $702,019.05 for 97,221 shares, this is the most they've acquired in one year. In 2011 David McIntyre cashed out on 73,349 shares for a total of $2,299,163.07, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HeartWare International, Inc. No price found
CFO & COO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.62K |
$53.41 | -$496,158.43 |
0
|
Scheduled
|
Dec 19 - Dec 20
| ||
Form 4
|
—
|
0
|
$55.16 | -$1,332,971.00 | 781 |
Scheduled
|
Sep 16 - Sep 19
| ||
Form 4
|
—
|
0
|
$87.70 | -$250,558.90 | 781 |
Scheduled
|
Feb 22
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
$71.39 | -$1,725,236.87 | 781 |
Scheduled
|
Sep 16 - Sep 17
| ||
Form 4
|
—
|
0
|
$38.14 | -$605,990.42 | 781 |
Scheduled
|
Apr 28 - Apr 30
| ||
Form 4
| -87.10% | -5.27K |
$38.50 | -$202,918.66 | 781 |
Scheduled
|
Mar 8 - Mar 9
| ||
Form 4
| -35.29% | -3.30K |
$39.32 | -$129,756.00 | 6.05K |
Feb 25
| |||
Form 4
| +1,097.44% | 8.57K |
—
|
—
| 9.35K |
Feb 22
| |||
Form 4
|
—
|
0
|
$34.20 | -$26,374.77 | 781 |
Scheduled
|
Jan 28
| ||
Form 4
|
—
|
0
|
$35.11 | -$2,946.00 | 781 |
Scheduled
|
Jan 20
| ||
Form 4
|
—
|
0
|
$28.08 | -$19,446.16 | 781 |
Scheduled
|
Dec 4 - Dec 7
| ||
Form 4
|
—
|
0
|
$27.98 | -$11,555.60 | 781 |
Scheduled
|
Dec 1 - Dec 3
| ||
Form 4
| -307.30% | -2.40K |
$24.88 | -$94,310.98 | 781 |
Scheduled
|
Nov 25 - Nov 30
| ||
Form 4
|
—
|
0
|
$25.77 | -$43,999.82 | 781 |
Scheduled
|
Nov 20 - Nov 24
| ||
Form 4
| -56.15% | -1.00K |
$32.17 | -$32,174.72 | 781 |
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 4
| -37.66% | -1.08K |
$22.59 | -$24,306.84 | 1.78K |
Jul 17
| |||
Form 4
| +357.13% | 2.86K |
—
|
—
| 3.66K |
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Avita Therapeutics, Inc. (RCEL) Snapshot price: $17.06
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +346.50% | 693 |
$23.20 | $16,076.10 | 893 |
Jul 16 - Jul 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||